They renamed PCOS to PMOS: What does this mean for people who have this hormonal condition.

 

PCOS has officially been renamed PMOS: What this means

PCOS is now PMOS

Polycystic Ovary Syndrome (PCOS) has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) as part of an international update in women’s health terminology.

This change reflects an evolving understanding of the condition as a multisystem endocrine and metabolic disorder, rather than a condition limited to the ovaries.

PMOS is estimated to affect approximately 1 in 8 women worldwide.

While the name has changed, the underlying condition remains the same.

Why the name was changed

The term “PCOS” has long been considered misleading, as it places emphasis on ovarian cysts, which are not present in all cases.

Research over the past two decades has consistently shown that the condition involves multiple body systems, including:

  • Hormonal regulation

  • Metabolic function

  • Insulin signalling

  • Reproductive function

The new term PMOS reflects this broader clinical understanding.

What PMOS means clinically

Polyendocrine Metabolic Ovarian Syndrome highlights three key components:

  • Polyendocrine: multiple hormone systems are affected

  • Metabolic: insulin resistance and metabolic dysfunction are common features

  • Ovarian: ovulatory dysfunction and androgen imbalance may be present

This updated terminology aims to improve diagnostic clarity and reduce misunderstanding of the condition.

What the research shows

Research consistently demonstrates that PCOS/PMOS is associated with:

  • Insulin resistance in a large proportion of individuals

  • Increased risk of type 2 diabetes and metabolic syndrome

  • Elevated cardiovascular risk markers

  • Chronic low-grade inflammation in many cases

  • Disrupted hypothalamic-pituitary-ovarian (HPO) axis signaling

These findings support the shift toward recognising PCOS as a metabolic-endocrine condition.

Does the diagnosis change?

No. The clinical diagnostic criteria remain the same during the transition period.

What is changing is:

  • The terminology used to describe the condition

  • The clinical framework used to understand its underlying mechanisms

  • The emphasis on metabolic and endocrine health in assessment

PCOS will still be referenced in clinical practice for some time as the transition to PMOS is adopted globally.

Key takeaway

The renaming of PCOS to PMOS reflects a significant update in medical understanding.

It recognises that this is not solely a reproductive condition, but a complex metabolic and endocrine disorder affecting multiple systems in the body.

 

Frequently Asked Questions (FAQ)

Is PCOS now officially called PMOS?

Yes. PCOS has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) as part of an international update in medical terminology. The transition is currently being implemented across clinical guidelines.

Why was PCOS renamed PMOS?

The name was changed to better reflect current research showing that the condition involves metabolic, hormonal, and endocrine systems, rather than being limited to ovarian features.

Does PMOS replace the diagnosis of PCOS?

No. The diagnostic criteria remain the same. The change is in terminology and clinical understanding, not in the underlying condition.

Is insulin resistance part of PMOS?

Yes. Insulin resistance is commonly associated with PMOS and is considered a key feature in many individuals.